Pa. Superior Court Won't Rehear Reglan Preemption Appeal

Law360, Philadelphia (October 7, 2013, 3:30 PM EDT) -- Pharmaceutical companies looking to dodge thousands of state law claims for alleged injuries related to generic versions of the digestive drug Reglan were dealt a loss Wednesday after the Pennsylvania Superior Court refused to rehear an appeal over whether the suits were preempted by federal law.

The court rejected a bid by Teva Pharmaceutical USA Inc. seeking an en banc rehearing of a July decision finding that thousands of Reglan-related product liability suits pending in the Philadelphia County Court of Common Pleas could survive preemption under...
To view the full article, register now.